PARI Group is headquartered in Starnberg, Germany, and has additional offices in Weilheim and Gräfelfing. In addition, the group branches are spread all over the world and have a global distribution network. The company has a business history of more than one hundred years, has about 500 employees and has a stable management team.

As a medical device manufacturer focusing on inhalation devices, PARI has been a brand trusted by doctors, pharmacists and patients for decades. Continuous product development and stable growth have allowed PARI to expand its leading position in the German market, saline and mist storage tanks. PARI is a global advanced enterprise in the field of inhalation equipment for pulmonary cystic fibrosis disease.

PARI provides specially optimized equipment and inhalation solutions for inhalation treatment of pulmonary, bronchial and nasopharyngeal diseases, with a broad portfolio of products used to provide patients with care from diagnosis and treatment to monitoring. PARI's mission is to improve the lives of patients and carers of respiratory diseases, and in addition to innovative products and customized inhalation solutions, PARI also serves users, medical professionals and distribution partners.

PARI's sprayers and inhalation devices are clinically validated and tested by millions of users, and have been trusted by medical experts and users for decades. They have been widely used in numerous product marketing authorization studies, which largely depends on their performance, as well as the "Made in Germany" quality under strict quality control. Successful efficacy can only be achieved after long and proper treatment, and quality has always been a priority for PARI: durable functionality and safety and hygiene.

In the future, PARI will continue to prioritize innovations that allow patients with respiratory diseases to receive the best possible care. PARI has two main R&D strategies: due to improved product friendliness: short inhalation time, product can be moved and easy to operate, and is designed to minimize patient workload. In addition, PARI is developing comprehensive treatment solutions for chronic respiratory diseases that will cover everything from diagnosis, aerosol inhalation therapy and respiratory physical therapy to health monitoring, with the goal of enabling doctors to provide patients with customized treatment options.